Lazard US Views 2026/2027
Considering making the jump from my current role as an ASO
Interested to hear the view analysts/professionals (including current/fmr. bankers at the firm) on Lazard, whether that be:
(i) Lazard 2030 and execution on that front / are the new rainmakers boosting the firm? The timing of this restructuring seems to have hurt them a little bit, especially as their rivals had a killer 2025.
(ii) deal-flow across M&A primarily in their ability to win large cap mandates like Evercore/Goldman/Centerview
(iii) general view on "prestige" and what juniors / incoming analysts think of the firm. I plan on staying in banking, but in case another opportunity arises, how are exits?
(iv) perception on the RX / HC / Industrials groups (along with other groups like Sovereign Advisory) which have long been the predominant coverages that drove Lazard. I know Power is doing very well.
bump, esp on exits for aso & above
Lazard HC def improving, last year was horrendous but they on the up again
What happened last year?
they did 1 deal all year
It is doing ok but it is not, and won't be anytime soon, at EVR/CVP's let alone GS' level in terms of perception or actual performance. That said, it is still a top firm
Any specific reason as to why?
bump, anecdotally have heard great things of culture as of recent
Bump
Overall M&A franchise (especially with this year’s performance) I would say is on par, if not slightly stronger than, PJT/MOE (their closest comps) but still need a few more years of consistent performance before we can say they’re at EVR/CVP level. Will caveat size-wise Laz is about 1/2 of EVR in the US and similar in size to MOE/CVP with PJT being smaller (by like ~25-30%).
Yes the restructuring had a big impact these past few years (a lot of underperforming MDs were pushed out which caused a short term decline in fees due to lost business) but this past year they’ve been making strong additions (see recent hires from BARC/MOE/BofA/Citi/others) which will bring in new business.
I think after taking over from Ken Jacobs, Peter Orszag realized the firm needed to stop relying on old school cachet and modernize (adapting similar playbooks that have worked at the newer boutiques like CVP/PJT/MOE and EVR). This required Laz to suffer somewhat in the short term but firm looks to be coming out stronger.
Does the firm have a larger focus on these larger cap mandates / board-room level advisory (things that CVP has been winning)?
Obviously up to the candidate to perform in buyside interviews but would say Laz is similar in HH perception to PJT M&A and MOE.
Maybe slightly behind EVR (on an overall basis especially as EVR’s Tech + Media + Comms groups have been outperforming). Tough to compare to CVP as CVP’s 3-year analyst program and high pay for A2As disincentivizes exits somewhat and makes oncycle trickier from a pure logistics POV.
Will caveat that this year there were more A2As at Lazard than in previous years as firm is incentivizing A2As by having the promotion take 2 years (vs. 3 which is the case at the other EBs) and offering other benefits (like 1 month PTO “sabbatical”, high promotion bonus, others) to A2As as well as firm-wide perks (1 month of remote work, WFH Monday + Friday, among other things). These, coupled with overcrowded PE mid-levels making path to promotion hard have made more analysts prefer to stay.
How do they compare against JPM?
This is more of a EB vs BB question (both sides have pros and cons) as both are strong platforms. I personally would pick LAZ for higher pay/prefer EB culture, but someone wanting a more general experience (across products) and global name might prefer JPM
Feels like their Power team has been ripping this year - those guys will probably eat good come bonus time.
I’m surprised they haven’t made strides in the technology M&A + some of the older cable M&C sectors like EVR/PJT/Q/CVP have or even MOE did when advising Netflix
Seemed like they got on the Meta raise, but if anyone has color on that would be great to hear
curious how ppl feel about the direction of the firm lately
not great, think the firm has fallen apart especially the RX and HC groups. more MDs getting fired for misconduct doesn't really send a positive signal
very misinformed take here, hc and rx have been doing rather well this year
couldnt be more wrong lmao
Bump
curious how deal flow has been looking lately
Prestige is still there, but juniors talk more about the grind these days.
What do you mean prestige still there (has it declined) AND grind? We have to grind and all our juniors talk about the grind nonstop
Been there. Lazard culture old-school, pay ok, deal flow RX heavy. 2030 restructuring hurt short-term. If u like HC/Industrials/RX go, else stay ASO. Exits prestige-dependent.
Ignore title. What’s your long-term view on the firm (ideally next 6-8 years?) also looking to move laterally
Also isn’t PEI their best group by deal flow
Exit opportunities are strong, but it really depends which group you land in.
Consequatur et ut ut voluptas doloribus et. Quia enim quos sit dignissimos dolores et. Distinctio quas totam ratione libero qui saepe. Qui consequuntur id laboriosam quia unde. Molestias quisquam corporis et deserunt. In ex itaque architecto qui.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Iure est laboriosam numquam. Beatae dicta assumenda suscipit harum voluptas adipisci.
Velit et ipsum iure sit occaecati tempora porro. Iusto deserunt laboriosam hic et. Aliquid reprehenderit in odio sed.
Fugiat rerum voluptatum nostrum tempora. Pariatur reiciendis sit necessitatibus. Vel qui omnis iure delectus optio. Maiores officia aut amet laborum inventore aut.
Voluptatibus beatae autem reprehenderit doloremque omnis velit. Et alias debitis dolores consequuntur culpa debitis qui. Nisi harum doloribus rerum in quam. Ut eos numquam soluta aliquam.